Levita Magnetics :: Robotic Systems Designed To Advance Minimally Invasive Surgery (MIS).

Levita Magnetics is a Silicon Valley-based medical technology company specializing in innovative magnetic and robotic systems designed to advance minimally invasive surgery (MIS). Founded in 2014 by surgeon-inventor Dr. Alberto Rodriguez-Navarro and co-founder Nicolas Luksic, the company is headquartered in Mountain View, California, with additional offices in Santiago, Chile. Levita’s mission is to improve patient outcomes, expand access to better surgery, and reduce the invasiveness of procedures through its proprietary Magnetic Surgery® technology.

The company’s core innovation lies in using external magnets to control internal retractors and instruments, eliminating the need for additional incisions or fixed trocars. This allows for reduced-port laparoscopic procedures, resulting in fewer scars, less post-operative pain, and faster patient recovery compared to traditional methods. Levita’s flagship product is the MARS™ (Magnetic-Assisted Robotic Surgery) Platform, a first-of-its-kind surgical system launched in 2023 that combines magnetic technology with robotics.

MARS features Dynamic Magnetic Positioning™, which provides expanded visualization and dynamic retraction of organs (such as the gallbladder, liver, or prostate) without the constraints of traditional tools. The system includes a surgeon-controlled robotic arm that reduces the need for additional assistive personnel, improves efficiency in high-volume abdominal surgeries (e.g., cholecystectomy, bariatric procedures), and maintains a compact footprint suitable for operating rooms and ambulatory surgery centers. Surgeons retain full direct control beside the patient, unlike many fully remote robotic systems.

Levita has achieved several regulatory and clinical milestones, including multiple FDA 510(k) clearances (with expanded indications for pediatric use and additional procedures). The platform has been used in landmark cases, such as the world’s first AI-guided autonomous surgery in Chile (2025), where AI-assisted camera guidance enhanced precision. Clinical benefits include fewer incisions, reduced staffing requirements, and improved ergonomics. The company has raised significant funding, including a $26 million Series C round in 2022, to support commercialization efforts.

With a focus on high-volume abdominal surgeries, Levita aims to make advanced robotic assistance more accessible and cost-effective for hospitals while prioritizing patient-centered outcomes. The team combines clinical expertise with engineering talent from companies like Stryker and Johnson & Johnson. As a privately backed innovator, Levita continues to push boundaries with integrations like augmented reality and AI to further evolve minimally invasive surgical care.